ADMA 241220 22.00P (ADMA241220P22000) Stock Options, News & Quotes

US OptionsDetailed Quotes

ADMA241220P22000

Watchlist

2.00
+0.68+51.52%

15min DelayClose Nov 29 13:00 ET

2.00High1.40Low

Intraday

5D
Daily

News

ADMA Biologics (NASDAQ:ADMA) Seems To Use Debt Quite Sensibly
Simply Wall StNov 28 10:00 ET
Adma Biologics (ADMA) Is on the Move, Here's Why the Trend Could Be Sustainable
Zacks Nov 27 08:00 ET
Insider Sale: CFO and Treasurer of $ADMA (ADMA) Sells 15,000 Shares
Quiver QuantitativeNov 22 21:16 ET
ADMA Biologics Announces Board Resignations and Appointments
TipRanksNov 21 16:57 ET
Mizuho Securities Maintains ADMA Biologics(ADMA.US) With Buy Rating, Maintains Target Price $24
Moomoo NewsNov 20 07:33 ET · Ratings
Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a Bet
Yahoo FinanceNov 15 09:30 ET

Comments

sharphooks

Nov 20 16:28

$ADMA Biologics (ADMA.US)$ woohoo

Krezash

Nov 8 04:03

$ADMA Biologics (ADMA.US)$ as expected, they smashed their earnings again 💵🔥

Krezash

Nov 1 05:05

Here we goooo

$ADMA Biologics (ADMA.US)$ getting one of the Big 4 to audit them and having their earnings in 7 days, this is going to shoot up in the next week 🚀

Krezash

Oct 31 20:23

$ADMA Biologics (ADMA.US)$ ADMA Biologics, Inc. (NASDAQ:ADMA), a biopharmaceutical company, announced on Thursday that it has appointed KPMG LLP as its new independent registered public accounting firm. The engagement with KPMG is effective immediately following the filing of ADMA's Quarterly Report for the fiscal quarter ended September 30, 2024.

Krezash

Oct 30 03:04

$ADMA Biologics (ADMA.US)$ Earnings on 7th November.. This is gonna surge like the last few earnings. It's a sure win 🚀🚀🚀